Trends in the surgical treatment for spinal metastasis and the in-hospital patient outcomes in the United States from 2000 to 2009
- PMID: 24291034
- DOI: 10.1016/j.spinee.2013.11.029
Trends in the surgical treatment for spinal metastasis and the in-hospital patient outcomes in the United States from 2000 to 2009
Abstract
Background context: Surgical treatment for spinal metastasis is still controversial. However, with the improvements in treatment for primary tumors, the survival rate of patients with spinal metastasis is enhanced. At the same time, surgical technique for spinal metastasis has also improved.
Purpose: The purpose of this study was to examine trends in the surgical treatment for spinal metastasis and in-hospital patient outcomes on a national level.
Study design/setting: This was an epidemiologic study using national administrative data from the Nationwide Inpatient Sample (NIS) database.
Patient sample: All discharges in the NIS with a diagnosis code of secondary malignant neoplasm of the spinal cord/brain, meninges, or bone who also underwent spinal surgery from 2000 to 2009 were included.
Outcome measures: Trends in the surgical treatment for spinal metastasis, in-hospital complications and mortality, and resource use were analyzed.
Methods: The NIS was used to identify patients who underwent surgical treatment for spinal metastasis from 2000 to 2009, using the International Classification of Diseases, Ninth revision, Clinical Modification codes. Trends in the surgical treatment for spinal metastasis and in-hospital patient outcomes were analyzed.
Results: From 2000 to 2009, there was an increasing trend in the population growth-adjusted rate of surgical treatment for spinal metastasis (1.15-1.77 per 100,000; p<.001). Average Elixhauser comorbidity score increased over time (2.6-3.8; p<.001), and the overall in-hospital complication rate increased over time (14.8%-27.7%; p<.001), whereas in-hospital mortality rate and length of hospital stay remained stable over time (5.2%-4.6%, p=.413; 10.6-10.8 days, p=.626). Inflation-adjusted mean hospital charges increased more than two-fold over time ($50,390-$110,173; p<.001).
Conclusions: During the last decade, surgical treatment for spinal metastasis has increased in the United States. The overall in-hospital complication rate and hospital charges increased, whereas the in-hospital mortality rate and length of hospital stay remained stable.
Keywords: Complication; Mortality; Nationwide Inpatient Sample; Spinal metastasis; Surgical treatment; Trend.
Copyright © 2014 Elsevier Inc. All rights reserved.
Similar articles
-
Epidemiology and national trends in prevalence and surgical management of metastatic spinal disease.J Clin Neurosci. 2018 Jul;53:183-187. doi: 10.1016/j.jocn.2018.04.022. Epub 2018 Apr 19. J Clin Neurosci. 2018. PMID: 29681425
-
Spinal fusion for pediatric neuromuscular scoliosis: national trends, complications, and in-hospital outcomes.J Neurosurg Spine. 2016 Oct;25(4):500-508. doi: 10.3171/2016.2.SPINE151377. Epub 2016 May 20. J Neurosurg Spine. 2016. PMID: 27203810
-
Increase in spinal deformity surgery in patients age 60 and older is not associated with increased complications.Spine J. 2017 May;17(5):627-635. doi: 10.1016/j.spinee.2016.11.005. Epub 2016 Nov 21. Spine J. 2017. PMID: 27884745
-
Discharge dispositions, complications, and costs of hospitalization in spinal cord tumor surgery: analysis of data from the United States Nationwide Inpatient Sample, 2003-2010.J Neurosurg Spine. 2014 Feb;20(2):125-41. doi: 10.3171/2013.9.SPINE13274. Epub 2013 Nov 29. J Neurosurg Spine. 2014. PMID: 24286530
-
Trends of the neurosurgical economy in the United States.J Clin Neurosci. 2018 Jul;53:20-26. doi: 10.1016/j.jocn.2018.04.041. Epub 2018 May 7. J Clin Neurosci. 2018. PMID: 29747898 Review.
Cited by
-
Trends in the surgical treatment for metastatic spinal tumor in Japanese administrative data between 2012 and 2020.Int J Clin Oncol. 2024 Jul;29(7):911-920. doi: 10.1007/s10147-024-02537-9. Epub 2024 Jun 3. Int J Clin Oncol. 2024. PMID: 38829471
-
Development and internal validation of machine-learning models for predicting survival in patients who underwent surgery for spinal metastases.Asian Spine J. 2024 Jun;18(3):325-335. doi: 10.31616/asj.2023.0314. Epub 2024 May 20. Asian Spine J. 2024. PMID: 38764230 Free PMC article.
-
Predictive Modeling for Spinal Metastatic Disease.Diagnostics (Basel). 2024 May 5;14(9):962. doi: 10.3390/diagnostics14090962. Diagnostics (Basel). 2024. PMID: 38732376 Free PMC article. Review.
-
Prognostic factors for surgical site infection in patients with spinal metastases and following surgical treatment.Medicine (Baltimore). 2024 Mar 15;103(11):e37503. doi: 10.1097/MD.0000000000037503. Medicine (Baltimore). 2024. PMID: 38489716 Free PMC article.
-
Implant and construct decision-making in metastatic spine tumour surgery: a review of current concepts with a decision-making algorithm.Eur Spine J. 2024 May;33(5):1899-1910. doi: 10.1007/s00586-023-07987-9. Epub 2024 Jan 30. Eur Spine J. 2024. PMID: 38289374 Review.
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
